- Home
- CHRS vs LVRO Comparison
CHRS vs LVRO Comparison
Compare CHRS & LVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- LVRO
- Stock Information
- Founded
- CHRS 2010
- LVRO 2017
- Country
- CHRS United States
- LVRO Brazil
- Employees
- CHRS N/A
- LVRO N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- LVRO Blank Checks
- Sector
- CHRS Health Care
- LVRO Finance
- Exchange
- CHRS Nasdaq
- LVRO Nasdaq
- Market Cap
- CHRS 195.3M
- LVRO 205.1M
- IPO Year
- CHRS 2014
- LVRO N/A
- Fundamental
- Price
- CHRS $1.68
- LVRO $1.24
- Analyst Decision
- CHRS Strong Buy
- LVRO Sell
- Analyst Count
- CHRS 4
- LVRO 3
- Target Price
- CHRS $4.51
- LVRO $1.88
- AVG Volume (30 Days)
- CHRS 1.0M
- LVRO 10.5K
- Earning Date
- CHRS 11-06-2025
- LVRO 10-31-2025
- Dividend Yield
- CHRS N/A
- LVRO N/A
- EPS Growth
- CHRS N/A
- LVRO N/A
- EPS
- CHRS 1.55
- LVRO N/A
- Revenue
- CHRS $272,209,000.00
- LVRO $1,667,345,189.00
- Revenue This Year
- CHRS N/A
- LVRO N/A
- Revenue Next Year
- CHRS $109.48
- LVRO $11.45
- P/E Ratio
- CHRS $3.29
- LVRO N/A
- Revenue Growth
- CHRS 52.33
- LVRO N/A
- 52 Week Low
- CHRS $0.66
- LVRO $1.24
- 52 Week High
- CHRS $2.43
- LVRO $5.60
- Technical
- Relative Strength Index (RSI)
- CHRS 52.98
- LVRO 30.24
- Support Level
- CHRS $1.64
- LVRO $1.33
- Resistance Level
- CHRS $1.81
- LVRO $1.49
- Average True Range (ATR)
- CHRS 0.10
- LVRO 0.09
- MACD
- CHRS -0.02
- LVRO -0.02
- Stochastic Oscillator
- CHRS 34.63
- LVRO 0.00
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About LVRO Lavoro Limited
Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.